scholarly journals Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis

2021 ◽  
Vol 10 (5) ◽  
pp. 1031
Author(s):  
Angelo Ruggiero ◽  
Gabriella Fabbrocini ◽  
Sara Cacciapuoti ◽  
Eleonora Cinelli ◽  
Lucia Gallo ◽  
...  
Keyword(s):  
Dry Eye ◽  
Inflammatory Disease ◽  
Chronic Inflammatory Disease ◽  
Ocular Involvement ◽  
Ophthalmological Examination ◽  
Ocular Manifestation ◽  
Ocular Manifestations ◽  
Ocular Symptoms ◽  
Immune Mediated ◽  
Ocular Disorders

Psoriasis is an immune-mediated, chronic inflammatory disease, which mainly affects the skin, although it has systemic pathological effects. Comorbidities of psoriasis include ocular disorders, which are often nonspecific or mildly symptomatic. The aim of this study was to show the importance of ocular-disease screening in psoriatic patients using the Ocular Manifestations in Psoriasis Screening (OcMaPS) questionnaire. Patients suffering from moderate-to-severe psoriasis referring at our outpatient-clinic were consecutively enrolled. Each patient was asked to complete a screening questionnaire (OcMaPS). Patients reporting ocular symptoms were referred for an ophthalmological examination. A total of 372 patients were enrolled in the study. Ocular symptoms were detected in 39 patients (10.5%), and 37 patients were referred to ophthalmological examination which confirmed the presence of ocular manifestation in 30 patients. There were three cases (10%) of uveitis, 14 (46.6%) of dry eye and 13 (43.3%) of cataract, in progress or already treated with surgery. In the remaining seven patients, no ocular manifestations were found. Ocular manifestations in psoriatic patients are not rare. It is important to be aware of ocular symptoms in psoriatic patients, screening patients (with a consultation or OcMaPS questionnaire), which leads to earlier diagnosis and treatment.

Ocular manifestations in patients who underwent COVID-19 in the early stages after Phaco surgery with implantation of IOL

2021 ◽  
pp. 80-85
Author(s):  
T.N. Savranova ◽  
◽  
V.U. Rozukulov ◽  
A.F. Yusupov ◽  
◽  
...  
Keyword(s):  
Dry Eye ◽  
Anterior Part ◽  
Anterior Segment ◽  
Early Postoperative Period ◽  
Posterior Segment ◽  
Vascular Pathology ◽  
Ocular Manifestations ◽  
Uveal Tract ◽  
Ocular Symptoms ◽  
Rehabilitation Period

Purpose. To study the ocular manifestations in patients with pseudophakia who underwent COVID-19 during the rehabilitation period after surgery. Material and methods. 46 patients with Phaco with implantation of IOL who underwent COVID-19 in the period from 1 week to 2 months after surgery. Of the examined patients, there were 28 men (61%), 18 women (391%). The average age of the patients was 63±1,2 years. Results. In 78% of cases, vascular pathology of the anterior and posterior segments of the eyeball was observed in patients who underwent COVID-19 in the early postoperative period after Phaco with implantation of IOL. Conclusions. The main ocular symptoms from the anterior segment of the eyeball in patients in 17% of cases were the occurrence or intensification of previously existing manifestations of the «dry eye» syndrome, as well as inflammatory phenomena from the anterior part of the uveal tract. From the posterior segment of the eye, in 70% of cases, there was a progression of vascular disorders, as well as the appearance of complications associated with manifestations of hypercoagulation syndrome and systemic vasculopathy. Key words: Covid-19, cataract phacoemulsification, pseudophakia.

scholarly journals Lichen Planus as a Possible Rare Cause of an Ocular Disease

2019 ◽  
Vol 75 (4) ◽  
pp. 219-223
Author(s):  
Jana Nekolová ◽  
Markéta Středová ◽  
Miroslav Podhola ◽  
Naďa Jirásková
Keyword(s):  
Lichen Planus ◽  
Inflammatory Disease ◽  
Ocular Surface ◽  
Negative Impact ◽  
Rare Event ◽  
Chronic Inflammatory Disease ◽  
Mental Condition ◽  
Unknown Etiology ◽  
Ocular Involvement ◽  
Irreversible Damage

Lichen planus is a relatively common mucocutaneous papulosquamous disorder of unknown etiology that is thought to be immunologically mediated. Ocular involvement of lichen planus (LP) is a rare event, which can lead to irreversible damage to the ocular surface and loss of vision from cicatrizing blepharoconjunctivitis and corneal scarring. Steroids are the first treatment choice. Treatment with topical ciclosporin A is also a possible treatment. We report a case of 79-year-old woman who was treated for long lasting severe inflammatory disease of a ocular surface. It led to blindness of one eye and low vision of the second eye. The diagnosis was made thanks to correlation of biopsy results from oral and ocular surface. The patient was also diagnosed with middle-stage dementia. Negative impact of steroid therapy on mental condition of this patient was considered. On the other hand, dementia could cause worse compliance with recommended treatment regime. Chronic inflammatory disease of ocular surface requires long lasting treatment very often and it is sometimes not as effective as expected. Discovering etiological causes of the disease is a priority for the right treatment. We emphasize also the key role of physical and mental condition in management of ocular surface disease.

Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database

2009 ◽  
Vol 85 (1003) ◽  
pp. 233-237 ◽  
Author(s):  
N Rajoriya ◽  
C J Wotton ◽  
D G R Yeates ◽  
S P L Travis ◽  
M J Goldacre
Keyword(s):  
Inflammatory Disease ◽  
Chronic Inflammatory Disease ◽  
Immune Mediated ◽  
Disease Associations

scholarly journals A Brief Overview Presented at Dry Eye University of Inflammation in Chronic Dry Eye Disease

2020 ◽  
Vol 3 ((SP1)) ◽  
pp. e17-e18
Author(s):  
Jerry Robben
Keyword(s):  
Chronic Inflammation ◽  
Dry Eye ◽  
Inflammatory Disease ◽  
Chronic Inflammatory Disease ◽  
Dry Eye Disease ◽  
Eye Disease ◽  
Common Enemy ◽  
And Control

Inflammation is a common enemy of any chronic inflammatory disease. Dry eye is no different. Once this diagnosis is made, then one of the first objectives is to address and control the chronic inflammation appropriately.

scholarly journals Eye and Rheumatology

2021 ◽  
pp. 419-428
Author(s):  
Abdullah A Al-ghamdi
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Juvenile Idiopathic Arthritis ◽  
Lupus Erythematosus ◽  
Visual Loss ◽  
Ocular Involvement ◽  
Ocular Manifestation ◽  
Systemic Lupus ◽  
Systemic Involvement ◽  
Rheumatologic Diseases ◽  
Ocular Manifestations

AbstractThe ocular involvement in rheumatology can be in a wide variety; it ranges from simple episcleritis to significant visual loss. Early detection followed by appropriate management can reserve vision. Ophthalmic involvement may occur in all of the rheumatic disorders. Ocular manifestation may be a presenting sign in some disorders, as in juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS), and Sjogren’s syndrome (SjS), or can be a presenting sign with the systemic involvement as in systemic lupus erythematosus (SLE), polyarteritis nodosa (PAN), granulomatosis with polyangiitis (GPA), and systemic sclerosis. Thus ocular manifestations in rheumatologic diseases (Table 19.1) can be the link in approaching the diagnosis.

scholarly journals A prevalence study of ocular manifestations in HIV positive patients on highly active anti-retroviral therapy

2019 ◽  
Vol 6 (7) ◽  
pp. 2950
Author(s):  
Hemal S. Hothi ◽  
Neepa R. Gohil ◽  
Nilesh V. Parekh ◽  
Sagar S. Patel
Keyword(s):  
Hiv Infection ◽  
Systemic Disease ◽  
Clinical Stage ◽  
Anterior Segment ◽  
Posterior Segment ◽  
Hiv Positive ◽  
Ocular Manifestation ◽  
Ocular Manifestations ◽  
Ocular Symptoms ◽  
Cell Counts

Background: Among 40 million cases worldwide, 50-75% of patients have at least one ocular manifestation in their lifetime. Many of ocular infections are treatable with therapeutic agents. Ocular manifestations invariably reflect systemic disease and can be the initial manifestations of HIV in many cases. Understanding of ocular sequel of HIV infection can lead to the early diagnosis and effective treatment. This study emphasizes on the need of developing a specific ophthalmic examination for the management of ocular manifestations in HIV infected patients.Methods: Cross sectional and observational study of 100 HIV positive participants on HAART were done irrespective of presence or absence of ocular symptoms. Participants were examined for complete ocular examination. Prevalence find out using chi-square test, find p values and ensuring statistical significance.Results: In our study, prevalence of ocular manifestation in HIV positive patients receiving HAART was 39%. Out of them, 20% adnexal involvement, 28% anterior segment involvement, 33% posterior segment involvement, 11% neuro-ophthalmic abnormality, 4% orbital involvement were present. 76% patients belonged to WHO clinical stage 2 and 3. 51% had CD4+ T cell counts <200 cells/µl.Conclusions: Posterior segment followed by anterior segment are the most commonly encountered ocular manifestations of HIV infection. Low CD4 count is good predictor for ocular manifestations in HIV positive patients. Higher WHO stage is also directly related with the severity of the ocular symptoms. Routine baseline ophthalmic screening to all HIV positive patients are necessary to prevent ocular morbidity.

scholarly journals Conjunctivitis and other ocular manifestation following COVID-19; updated information about transmission of COVID-19 by eye

2021 ◽  
Vol 7 (2) ◽  
pp. e28-e28
Author(s):  
Mohsen Mirshamsi ◽  
Nasrin Ghiasi ◽  
Sharareh Heidari ◽  
Parisa Hosseinpour ◽  
Babak Hassanlouei ◽  
...  
Keyword(s):  
Foreign Body ◽  
Dry Eye ◽  
Health Problem ◽  
Contact Lenses ◽  
Ocular Symptom ◽  
Current Evidence ◽  
Ocular Involvement ◽  
Ocular Manifestation ◽  
Conjunctival Hyperemia ◽  
Body Sensation

Coronavirus disease 2019 (COVID-19) was reported in Wuhan, in late December 2019 and was became a pandemic health problem worldwide. In this review, the current evidence related to the ocular transmission of SARS-CoV-2 and its common manifestations was studied. According to this review, 7% to 69.4% of patients had at least an ocular symptom following COVID-19. Ocular symptom are bilateral or unilateral conjunctivitis, increased secretion, eye itching and foreign body sensation, epiphora, dry eye, conjunctival congestion, eye pink, conjunctival hyperemia, and chemosis. SARS-CoV-2 particles were found in tears and conjunctiva. Therefore, the transmission of COVID-19 by conjunctiva is possible. Then, it is essential to wear eye shield to protect against developing ocular involvement by COVID-19 because personal glasses and contact lenses cannot protect from COVID-19.

scholarly journals Ocular manifestation of rheumatoid arthritis-different forms and frequency

2010 ◽  
Vol 10 (4) ◽  
pp. 323-327 ◽  
Author(s):  
Gordana Zlatanović ◽  
Dragan Veselinović ◽  
Sonja Cekić ◽  
Maja Živković ◽  
Jasmina Đorđević- Jocić ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Keratoconjunctivitis Sicca ◽  
Anterior Segment ◽  
Retinal Vasculitis ◽  
Applanation Tonometry ◽  
Ocular Involvement ◽  
Ocular Manifestation ◽  
Posterior Scleritis ◽  
Ocular Manifestations ◽  
Systemic Inflammatory Disease

Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with a number of extra-articular organ manifestations. Ocular manifestations involved with RA are keratoconjunctivitis sicca, episcleritis, scleritis, corneal changes, and retinal vasculitus. The etiopathogenesis of this autoimmune disorder is still unknown. Aim of our study was to present different ocular manifestations of RA and their frequency. We have examined 691 patient with the diagnoses of RA. All examined patients were in I or II stage of the disease according to criteria of The American College of Rheumatology. Ophthalmological exam obtained: visual acuity by Snellen sings, biomicroscopy of anterior segment, Schirmer test, tear break-up time (BUT), applanation tonometry and indirect ophthalmoscopy. In all patients with retinal vasculitis fotofundus and in indicated cases fluorescein angiography was preformed. The most common manifestation of ocular involvement was keratoconjunctivitis sicca. Episcleritis was diagnosed in 5.06% patients with RA, while scleritis was present in 2.06% of patients. Diffuse scleritis was present in one patient, while nodular was present in 13 patients. There were no patients with posterior or necrotizing scleritis among examined patients. Sclerosing keratitis was diagnosed in 11 female patients. It is characterized with peripheral thickening and opacification of the stroma adjacent to the site of inflammation. Posterior scleritis or scleromalacia of cornea was not present in our patients, because all of them were in I or II stage of disease. Retinal vasculitis was present in three patients, two male and one female patient (0.45%). Ocular manifestation was present in 27.2% of patients. Women were more affected.

Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up

2019 ◽  
Vol 104 (2) ◽  
pp. 235-240
Author(s):  
Antoine Rousseau ◽  
Catherine Prost-Squarcioni ◽  
Serge Doan ◽  
Christelle Leroux-Villet ◽  
Frédéric Caux ◽  
...  
Keyword(s):  
Epidermolysis Bullosa ◽  
Epidermolysis Bullosa Acquisita ◽  
Ocular Involvement ◽  
Ophthalmological Examination ◽  
Ocular Manifestations ◽  
Systemic Treatments ◽  
Long Term Follow Up ◽  
Triggering Factor

Background/aimsTo describe the ocular manifestations associated with epidermolysis bullosa acquisita (EBA).MethodsThis retrospective study was conducted at a tertiary bullous disease clinic. Consecutive patients were enrolled with biopsy proven diagnosis of EBA, with ocular involvement and a follow-up of at least 36 months. A multidisciplinary team of dermatologists, ENT specialists and ophthalmologists evaluated all patients. Immunological workup included direct (including immune-electron microscopy) and indirect immunofluorescence. Ophthalmological examination included best-corrected visual acuity (BCVA) and slit-lamp examination with grading of conjunctival fibrosis using the Tauber classification.ResultsNine patients (five females, four males) were included. The mean age at diagnosis was 32 years (range 1–52 years). Follow-up ranged from 3 to 18 years (mean 10.7 years). Conjunctival fibrosis was present in all affected eyes and was stage III or greater in 60% of patients. Eight patients (14 eyes) had corneal involvement most frequently associated with trichiasis-associated mechanical irritation or extensive cicatrising conjunctivitis. Corneal lesions developed on three eyes of three patients without eyelid disease or severe fibrosis or any identifiable triggering factor. Eyelids were affected in six patients, with trichiasis being the most common feature (affecting three patients, four eyes). Corneal-related blindness occurred in at least one eye in 44% of the patients.ConclusionEBA may be associated with devastating ocular manifestations. Most patients develop severe cicatrising conjunctivitis. A subset of patients may present with isolated corneal lesions. Further studies are warranted to assess the effects of systemic treatments on the evolution of ocular manifestations.

Sign in / Sign up

Export Citation Format

Share Document